The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Inflammatory bowel disease: Epidemiology, pathogenesis, and therapeutic opportunities
Abstract
Ulcerative colitis (UC) and Crohn's disease (CD), the primary constituents of inflammatory bowel disease (IBD), are precipitated by a complex interaction of environmental, genetic, and immunoregulatory factors. Higher rates of IBD are seen in northern, industrialized countries, with greater prevalence among Caucasians and Ashkenazic Jews. Racial gaps are closing, indicating that environmental factors may play a role. IBD is multigenic, with the most clearly established genetic link between certain NOD2 variants and CD. Regardless of the underlying genetic predisposition, a growing body of data implicates a dysfunctional mucosal immune response to commensal bacteria in the pathogenesis of IBD, especially CD. Possible triggers include a chronic inflammatory response precipitated by infection with a particular pathogen or virus or a defective mucosal barrier. The characteristic inflammatory response begins with an infiltration of neutrophils and macrophages, which then release chemokines and cytokines. These in turn exacerbate the dysfunctional immune response and activate either TH1 or TH2 cells in the gut mucosa, respectively associated with CD and, less conclusively, with UC. Elucidation of immunological and genetic factors indicate multiple points at which the inflammatory cascade may be interrupted, yielding the possibility of precise, targeted therapies for IBD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sellon, R. K., Tonkonogy, S., Schultz, M., Dieleman, L. A., Grenther, W., Balish, E., Rennick, D. M., & Sartor, R. B. (1998) · Infection and Immunity · doi:10.1128/iai.66.11.5224-5231.1998 · Cited by 1,483
Cited by
Mechanisms Regulating Intestinal Barrier Integrity and Its Pathological Implications
Chelakkot, C., Ghim, J., & Ryu, S. H. (2018) · Experimental & Molecular Medicine · doi:10.1038/s12276-018-0126-x · Cited by 2,017
Microbial pathways in colonic sulfur metabolism and links with health and disease
Carbonero, F., Benefiel, A. C., Alizadeh-Ghamsari, A. H., & Gaskins, H. R. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00448 · Cited by 544
Willing, B., Halfvarson, J., Dicksved, J., Rosenquist, M., Järnerot, G., Engstrand, L., Tysk, C., & Jansson, J. K. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20783 · Cited by 455
Chang, J., Leong, R. W., Wasinger, V. C., Ip, M., Yang, M., & Phan, T. G. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.05.056 · Cited by 286
A meta-analytic review of the psychosocial adjustment of youth with inflammatory bowel disease
Greenley, R. N., Hommel, K. A., Nebel, J., Raboin, T., Li, S.-H., Simpson, P., & Mackner, L. (2010) · Journal of Pediatric Psychology · doi:10.1093/jpepsy/jsp120 · Cited by 259
Zhang, X., Chen, Y., He, H., Wang, S., Lei, Z., & Zhang, F. (2021) · Angewandte Chemie International Edition · doi:10.1002/anie.202109728 · Cited by 176
Isotretinoin use and the risk of inflammatory bowel disease: a case-control study
Crockett, S. D., Porter, C. Q., Martin, C. F., Sandler, R. S., & Kappelman, M. D. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2010.124 · Cited by 161
Victoria, C. R., Sassak, L. Y., & Nunes, H. R. D. C. (2009) · Arquivos de Gastroenterologia · doi:10.1590/s0004-28032009000100009 · Cited by 156
Saha, S., Jing, X., Park, S. Y., Wang, S., Li, X., Gupta, D., & Dziarski, R. (2010) · Cell Host & Microbe · doi:10.1016/j.chom.2010.07.005 · Cited by 137
Sands, B. E., Jacobson, E. W., Sylwestrowicz, T., Younes, Z., Dryden, G., Fedorak, R., & Greenbloom, S. (2010) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21159 · Cited by 114
Isotretinoin use and the risk of inflammatory bowel disease: a population-based cohort study
Alhusayen, R. O., Juurlink, D. N., Mamdani, M. M., Morrow, R. L., Shear, N. H., & Dormuth, C. R. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.387 · Cited by 84
Decreasing incidence of inflammatory bowel disease in Eastern Canada: a population database study
Leddin, D., Tamim, H., & Levy, A. R. (2014) · BMC Gastroenterology · doi:10.1186/1471-230x-14-140 · Cited by 61
Gut microbiota and inflammatory bowel disease: the role of antibiotics in disease management
Kerman, D. H., & Deshpande, A. R. (2014) · Postgraduate Medicine · doi:10.3810/pgm.2014.07.2779 · Cited by 47
Trindade, I. A., Ferreira, C., & Pinto-Gouveia, J. (2016) · Journal of Health Psychology · doi:10.1177/1359105315587142 · Cited by 33
Seoane-Viaño, I., Gómez-Lado, N., Lázare-Iglesias, H., Rey-Bretal, D., Lamela-Gómez, I., Otero-Espinar, F. J., Blanco-Méndez, J., Antúnez-López, J. R., Pombo-Pasín, M., Aguiar, P., et al. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.118713 · Cited by 24
Inflammatory bowel disease in Bahrain: single-center experience
Abdulla, M., Al Saeed, M., Fardan, R. H., Alalwan, H. F., Ali Almosawi, Z. S., Almahroos, A. F., & Al Qamish, J. (2017) · Clinical and Experimental Gastroenterology · doi:10.2147/ceg.s127909 · Cited by 22
Williams, A. B., Heider, F., Messling, J.-E., Rieckher, M., Bloch, W., & Schumacher, B. (2019) · Genetics · doi:10.1534/genetics.119.302422 · Cited by 10
Metadata
- Authors
- Hanauer, S. B.
- Venue
- Inflammatory Bowel Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-01
- Volume
- 12
- Pages
- S3-S9
- ISSN
- 1078-0998 (ISSN-L)
- OpenAlex
- W2057447694
- Cited by
- 968
- References
- 1
- FWCI
- 19.16
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
